DH5a Competent Cells: Mechanism, Protocol, and Best Practices

By Dr. Zubair Khalid, DVM, MS, PhD ·

DH5a Competent Cells: Mechanism, Protocol, and Best Practices

Introduction to DH5a Competent Cells

DH5a is a laboratory strain of Escherichia coli K-12 that has become the default workhorse for plasmid cloning and propagation in molecular biology laboratories worldwide. Developed in the 1980s by Douglas Hanahan, the strain was engineered to address the practical needs of recombinant DNA work: high transformation efficiency, stable plasmid maintenance, and convenient screening of recombinant clones. The "a" in DH5a denotes a specific derivative of the original DH5 strain, distinguished by a deletion in the lacZ gene that enables blue-white color screening.

The strain's enduring popularity stems from a combination of genetic modifications that collectively optimize it for cloning applications. Unlike wild-type E. coli, DH5a lacks restriction-modification systems that would otherwise degrade foreign DNA, carries mutations that improve DNA uptake, and has been rendered incapable of horizontal gene transfer through conjugation. These features, combined with its robust growth characteristics and compatibility with standard antibiotic selection markers, make DH5a the first choice for routine plasmid construction, subcloning, and plasmid DNA preparation.

Genotype and Key Mutations

The complete genotype of DH5a is: F⁻ φ80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 hsdR17(rK⁻, mK⁺) phoA supE44 thi-1 gyrA96 relA1 λ⁻. Each component of this genotype contributes specific properties that are critical for cloning work.

The recA1 mutation is perhaps the most important for plasmid stability. RecA is the central enzyme in homologous recombination in E. coli. By inactivating RecA, the strain cannot efficiently recombine repeated sequences, which prevents unwanted rearrangements of plasmid DNA, particularly those containing repetitive elements or direct repeats. This mutation also reduces the frequency of plasmid multimer formation, ensuring that isolated plasmids are predominantly monomeric and structurally intact.

The endA1 mutation eliminates endonuclease I, a periplasmic enzyme that degrades double-stranded DNA. In wild-type cells, EndA is released during cell lysis and can degrade plasmid DNA during miniprep procedures, leading to poor yields and degraded DNA. The endA1 mutation is therefore essential for obtaining high-quality plasmid preparations with standard alkaline lysis kits.

The hsdR17 mutation abolishes the EcoKI restriction endonuclease activity while preserving the corresponding methylase (rK⁻, mK⁺). This means that incoming foreign DNA lacking the E. coli methylation pattern is not degraded by the restriction system, yet the strain can still methylate its own DNA at the appropriate sites. This is critical for cloning DNA from other organisms, as unmethylated foreign DNA would otherwise be destroyed immediately upon entry.

The lacZ mutations are designed for blue-white screening. The φ80lacZΔM15 mutation provides the omega fragment of β-galactosidase, while the Δ(lacZYA-argF)U169 chromosomal deletion removes the endogenous lacZ gene. Together, these create a system where α-complementation can occur: if a plasmid vector carries the lacZα fragment, the two protein fragments assemble into a functional β-galactosidase enzyme. When the lacZα coding sequence is interrupted by an inserted DNA fragment, no functional enzyme is produced. This forms the basis for distinguishing recombinant from non-recombinant colonies on X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) plates.

Additional mutations include gyrA96 (conferring nalidixic acid resistance), relA1 (relaxed control of stringent response), supE44 (suppressor of amber mutations), thi-1 (thiamine auxotrophy), and phoA (alkaline phosphatase deficiency). The F⁻ phenotype indicates the absence of the F plasmid, making the strain unable to support conjugation or M13 phage infection.

Applications in Molecular Cloning

DH5a is optimized for the propagation of plasmid DNA, not for protein expression. Its primary applications include subcloning DNA fragments into plasmid vectors, maintaining and amplifying plasmid stocks, generating libraries of transformed clones, and preparing plasmid DNA for downstream applications such as sequencing, restriction digestion, or transfection into mammalian cells. The strain's high transformation efficiency—typically 10⁶ to 10⁹ colony-forming units per microgram of supercoiled plasmid DNA depending on preparation method—ensures that even small amounts of ligation product yield sufficient colonies for screening.

DH5a is not suitable for expressing recombinant proteins under strong promoters, as it lacks the specialized protease-deficient or chaperone-overexpressing backgrounds found in expression strains like BL21(DE3). It is also not ideal for cloning large DNA fragments (>10 kb) or unstable sequences, for which strains like Stellar Competent Cells or Competent Cell Stbl3 may be more appropriate.

The Biology of Competence and Transformation

Transformation is the process by which bacteria take up exogenous DNA from their environment and stably maintain it. In nature, this occurs through natural competence, a physiological state that some bacterial species enter under specific environmental conditions. E. coli, however, does not naturally become competent; it must be artificially induced to take up DNA in the laboratory.

Natural Competence vs. Artificial Induction

Natural competence is a genetically programmed physiological state found in bacteria such as Bacillus subtilis, Streptococcus pneumoniae, and Neisseria gonorrhoeae. These species express dedicated DNA uptake machinery, including competence pili and DNA-binding proteins, when they sense conditions such as nutrient limitation, high cell density, or DNA damage. The imported DNA is often used for homologous recombination or as a nutrient source.

E. coli lacks these natural competence systems. To transform E. coli, researchers must artificially induce a state of DNA permeability through chemical treatment or physical methods. The most common approach is the calcium chloride method, which was developed in the 1970s by Mandel and Higa. This method involves treating log-phase cells with cold calcium chloride, which alters the cell envelope and creates a state where DNA can bind to the cell surface and be internalized upon a brief heat shock.

The molecular mechanism of chemically induced competence is not fully understood, but it is believed to involve several coordinated changes. Calcium ions interact with the negatively charged lipopolysaccharide (LPS) molecules in the outer membrane, neutralizing electrostatic repulsion and promoting the binding of negatively charged DNA to the cell surface. The cold incubation step likely induces changes in membrane fluidity and the expression of cold-shock proteins that facilitate DNA uptake. The subsequent heat shock (typically 42°C for 30–90 seconds) creates a thermal gradient that drives the membrane through a phase transition, allowing DNA to cross the membrane barriers.

Role of Cell Wall and Membrane in DNA Uptake

The E. coli cell envelope is a complex multi-layered structure that presents a formidable barrier to DNA entry. The outer membrane contains LPS, which carries a net negative charge due to phosphate groups in the lipid A and core oligosaccharide regions. This negative charge repels the negatively charged phosphate backbone of DNA. Calcium ions bridge these charges, allowing DNA to bind to the outer membrane surface.

The peptidoglycan layer lies beneath the outer membrane and provides structural rigidity. During transformation, this layer must be traversed by the incoming DNA. The heat shock step is thought to create transient pores or disruptions in the peptidoglycan that permit DNA passage. The inner (cytoplasmic) membrane is the final barrier, and its lipid bilayer must be transiently permeabilized for DNA to enter the cytoplasm.

Electroporation offers an alternative physical method for transformation. In this approach, cells are subjected to a brief, high-voltage electrical pulse (typically 1.5–2.5 kV in a 0.1 cm cuvette) that creates transient pores in the cell membrane through dielectric breakdown. Electroporation can achieve transformation efficiencies of 10⁹–10¹⁰ CFU/µg for DH5a, which is 10–100-fold higher than chemical methods. However, electroporation requires specialized equipment and more careful cell preparation, as the cells must be extensively washed to remove salts that would conduct electricity and cause arcing.

Preparing DH5a Competent Cells

While commercially prepared Chemically Competent Cells are convenient and consistent, many laboratories prepare their own DH5a competent cells to reduce costs or when specific modifications are needed. The protocol below describes the preparation of chemically competent cells using the calcium chloride method, which yields efficiencies of approximately 10⁶–10⁷ CFU/µg.

Growth and Harvesting

  1. Inoculate a single colony of DH5a from a fresh LB agar plate into 5 mL of LB broth (10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl). Incubate overnight at 37°C with shaking at 200–250 rpm.
  1. Subculture 1 mL of the overnight culture into 100 mL of pre-warmed LB broth in a 500 mL Erlenmeyer flask. Grow at 37°C with vigorous shaking (250 rpm) until the optical density at 600 nm (OD₆₀₀) reaches 0.4–0.6. This typically takes 2–3 hours. Do not exceed OD₆₀₀ of 0.6, as cells in late log or stationary phase have reduced competence.
  1. Chill the culture on ice for 10–15 minutes. All subsequent steps must be performed at 4°C or on ice to maintain cell viability and competence.
  1. Harvest the cells by centrifugation at 4,000 × g for 10 minutes at 4°C. Use pre-chilled centrifuge tubes and rotors.
  1. Decant the supernatant completely and resuspend the cell pellet gently in 30 mL of ice-cold 0.1 M CaCl₂. The resuspension should be performed by pipetting or gentle swirling, not vortexing, to avoid cell damage.
  1. Incubate on ice for 30 minutes.
  1. Centrifuge again at 4,000 × g for 10 minutes at 4°C.
  1. Decant the supernatant and resuspend the pellet in 4 mL of ice-cold 0.1 M CaCl₂ containing 15% glycerol (v/v). This is the final competent cell suspension.

Calcium Chloride Treatment

The calcium chloride treatment serves two purposes: it alters the outer membrane to promote DNA binding, and it creates a state of "competence" that is maintained at cold temperatures. The concentration of CaCl₂ is critical; 0.1 M is standard, but some protocols use 50 mM or 100 mM with varying success. The presence of divalent cations other than calcium, such as magnesium or manganese, can also influence efficiency. Some protocols include a "transformation buffer" containing 10 mM MES (2-(N-morpholino)ethanesulfonic acid) pH 6.3, 100 mM KCl, 45 mM MnCl₂, 10 mM CaCl₂, and 3 mM HEPES, which can yield higher efficiencies.

The glycerol in the final resuspension serves as a cryoprotectant, preventing ice crystal formation that would damage cell membranes during freezing. Without glycerol, cell viability and competence are severely reduced after freezing and thawing.

Storage and Quality Control

Aliquot the competent cell suspension into pre-chilled, sterile microcentrifuge tubes in volumes appropriate for single transformations (typically 50–100 µL). Snap-freeze the aliquots in liquid nitrogen or a dry ice-ethanol bath, then store at −80°C. Under these conditions, DH5a competent cells can be stored for 6–12 months without significant loss of efficiency. For long-term storage, see Cryopreserve Cells for general principles.

Quality control should include a test transformation with a known supercoiled plasmid (e.g., pUC19) to determine transformation efficiency. A typical preparation should yield at least 10⁶ CFU/µg. Also verify that the cells are viable by plating an aliquot on LB agar without antibiotics; the expected viability is 10⁸–10⁹ CFU/mL.

Transformation Protocol Using DH5a Cells

The transformation protocol for DH5a competent cells is straightforward but requires attention to timing and temperature. The standard heat-shock method is described below, followed by the electroporation alternative.

Heat-Shock Method

  1. Thaw an aliquot of DH5a competent cells on ice for 5–10 minutes. Do not thaw at room temperature or in a water bath, as this reduces efficiency.
  1. Add 1–10 ng of plasmid DNA or 5–20 µL of a ligation reaction to the cells. The volume of DNA should not exceed 10% of the cell volume. Mix gently by tapping the tube; do not pipette up and down, as this can damage the cells.
  1. Incubate on ice for 30 minutes. This allows DNA to bind to the cell surface.
  1. Heat shock the cells by transferring the tube to a 42°C water bath for exactly 30–45 seconds. The optimal time varies slightly between protocols; 30 seconds is standard for 100 µL aliquots. Do not exceed 60 seconds, as this can kill the cells.
  1. Return the tube to ice for 2 minutes.
  1. Add 900 µL of pre-warmed (37°C) SOC medium (2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl₂, 10 mM MgSO₄, 20 mM glucose) or LB broth. SOC medium provides better recovery due to the presence of magnesium and glucose.
  1. Recover the cells by incubating at 37°C with shaking at 200–250 rpm for 45–60 minutes. This recovery period allows the cells to express antibiotic resistance genes before plating.
  1. Plate appropriate volumes (typically 50–200 µL) onto LB agar plates containing the appropriate antibiotic. For ligation reactions, plate multiple volumes to ensure at least one plate has well-separated colonies.

Electroporation Method

Electroporation requires electrocompetent cells, which are prepared by washing log-phase cells extensively in ice-cold 10% glycerol to remove all salts. The protocol is as follows:

  1. Thaw electrocompetent DH5a cells on ice.
  1. Add 1–2 µL of DNA (1–100 ng) to 50 µL of cells. The DNA must be salt-free; desalt ligation reactions by ethanol precipitation or using a commercial cleanup kit.
  1. Transfer the cell-DNA mixture to a pre-chilled 0.1 cm electroporation cuvette. Ensure the mixture covers the bottom of the cuvette.
  1. Electroporate using a Bio-Rad Gene Pulser or equivalent set to 1.8 kV, 25 µF capacitance, and 200 Ω resistance. The time constant should be 4–5 milliseconds.
  1. Immediately add 950 µL of pre-warmed SOC medium to the cuvette and gently resuspend the cells.
  1. Transfer the suspension to a sterile tube and recover at 37°C with shaking for 45–60 minutes.
  1. Plate as described above.

Electroporation routinely yields 10⁹–10¹⁰ CFU/µg with supercoiled plasmid DNA, making it the method of choice when maximum efficiency is required, such as when transforming large or unstable constructs.

Recovery and Plating

The recovery step is critical for transformation success. During recovery, the cells must synthesize the antibiotic resistance proteins encoded by the plasmid before being exposed to the selective antibiotic. A recovery time of 45–60 minutes is generally sufficient for ampicillin, kanamycin, and chloramphenicol resistance markers. For zeocin or other antibiotics, longer recovery times (up to 2 hours) may be necessary.

When plating, use pre-warmed plates and spread the cells gently with sterile glass beads or a spreader. Avoid using a metal spreader that has been flamed, as the residual heat can kill the cells. For ligation reactions, plate 10–50 µL and 100–200 µL on separate plates to ensure that at least one plate yields well-separated colonies.

Factors Affecting Transformation Efficiency

Transformation efficiency is defined as the number of colony-forming units (CFU) obtained per microgram of plasmid DNA. For DH5a, typical efficiencies range from 10⁶ CFU/µg for homemade chemically competent cells to 10⁹ CFU/µg for commercial high-efficiency preparations. Several factors critically influence this metric.

DNA Quality and Quantity

The purity and structural form of the DNA are paramount. Supercoiled plasmid DNA transforms at 10–100-fold higher efficiency than linear or nicked DNA. This is because the cell's exonuclease activities rapidly degrade linear DNA upon entry. For ligation reactions, the DNA should be purified to remove salts, proteins, and residual ligase buffer components, all of which can inhibit transformation. Ethanol precipitation followed by a 70% ethanol wash is the standard method for desalting.

The amount of DNA used also matters. Within the range of 1 pg to 100 ng, transformation efficiency (CFU/µg) is relatively constant for supercoiled DNA. However, at very high DNA concentrations (>1 µg), efficiency per microgram decreases, likely due to saturation of the DNA uptake machinery. For ligation reactions, using 5–20 µL of a standard 10 µL ligation reaction is typical.

Cell Density and Competence State

The physiological state of the cells at the time of harvest is critical. Cells harvested at OD₆₀₀ 0.4–0.6 are in mid-log phase, when they are most metabolically active and most amenable to competence induction. Cells harvested at higher densities have reduced competence, likely because they have begun to enter stationary phase and have altered cell envelope composition.

The competence state is also affected by the growth medium. Rich media such as LB produce cells with higher transformation efficiency than minimal media. The presence of magnesium in the growth medium is important for maintaining cell viability during the competence induction process.

Temperature and Timing

The temperature and duration of each step in the transformation protocol are tightly optimized. The 30-minute ice incubation allows DNA to bind to the cell surface; shorter times reduce DNA binding, while longer times do not improve efficiency. The heat shock must be brief and at the correct temperature; 42°C for 30–45 seconds is optimal for DH5a. Temperatures above 42°C or longer exposure times kill the cells, while lower temperatures or shorter times result in incomplete DNA uptake.

The recovery period is also temperature-sensitive. Cells recover best at 37°C with shaking; static recovery at room temperature is less efficient. The recovery medium should be pre-warmed to 37°C to avoid cold shock.

Selection and Screening of Transformants

After transformation, the cells are plated on selective media to identify those that have acquired the plasmid. DH5a supports two common screening methods: antibiotic resistance selection and blue-white color screening.

Antibiotic Selection

Plasmid vectors carry antibiotic resistance genes that allow selective growth of transformed cells. The most common selectable markers in cloning vectors include:

AntibioticMechanism of ResistanceTypical Concentration
Ampicillinβ-lactamase (bla) inactivates the antibiotic50–100 µg/mL
KanamycinAminoglycoside phosphotransferase (neo/kan) modifies the antibiotic30–50 µg/mL
ChloramphenicolChloramphenicol acetyltransferase (cat) acetylates the antibiotic25–34 µg/mL
TetracyclineEfflux pump (tet) exports the antibiotic10–15 µg/mL

Ampicillin is the most commonly used marker in cloning vectors like pUC19 and pBluescript. However, ampicillin is degraded by β-lactamase secreted into the medium, which can lead to the growth of satellite colonies—non-transformed cells that grow in the zone of degraded antibiotic surrounding transformed colonies. This issue is discussed further in the troubleshooting section.

Blue-White Screening

Blue-white screening exploits the lacZ mutations in DH5a. The vector (e.g., pBluescript, pUC19) carries the lacZα gene encoding the α-peptide of β-galactosidase. When the vector is present, α-complementation occurs, and the cells produce functional β-galactosidase. This enzyme cleaves X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside), producing a blue precipitate.

When a DNA fragment is inserted into the multiple cloning site (MCS) located within the lacZα gene, the α-peptide is disrupted, and no functional β-galactosidase is produced. These recombinant colonies remain white on X-gal plates. The screening requires plates containing X-gal (40 µg/mL) and IPTG (isopropyl β-D-1-thiogalactopyranoside, 0.5 mM), which induces expression of the lac operon.

It is important to note that blue-white screening is not foolproof. Small insertions (<100 bp) may not disrupt the lacZα reading frame sufficiently to eliminate β-galactosidase activity, resulting in light blue colonies. Additionally, some non-recombinant colonies may appear white if the vector has undergone deletion of the lacZα region. Therefore, blue-white screening should be followed by confirmatory methods.

Colony PCR and Plasmid Prep

Colony PCR is a rapid method to verify the presence of the insert in transformants. A small amount of a single colony is transferred to a PCR reaction containing primers that flank the MCS. After an initial denaturation step (95°C for 5 minutes) to lyse the cells, 25–35 cycles of amplification are performed. The PCR product is analyzed by agarose gel electrophoresis; the size of the product indicates whether the insert is present and its approximate size.

For final confirmation, plasmid DNA is prepared from positive colonies using a miniprep kit or alkaline lysis. The purified plasmid is then analyzed by restriction digestion, which should release fragments of the expected sizes, and by Sanger sequencing using vector-specific primers.

Common Pitfalls and Troubleshooting

Despite the simplicity of DH5a transformation, several common problems can arise. The following section addresses the most frequent failure modes and their solutions.

Low Transformation Efficiency

Low efficiency is the most common complaint. The causes are numerous:

  • Cells harvested at incorrect OD₆₀₀: Cells must be in mid-log phase (OD₆₀₀ 0.4–0.6). Overgrown cultures yield poorly competent cells.
  • Incorrect heat shock temperature or time: The heat shock must be at exactly 42°C for 30–45 seconds. Use a calibrated water bath, not a heat block, as heat blocks have slower thermal transfer.
  • DNA contains inhibitors: Residual salts, proteins, or detergents from ligation reactions or plasmid preps inhibit transformation. Purify the DNA by ethanol precipitation or spin column.
  • Cells were thawed incorrectly: Thaw cells on ice only. Thawing at room temperature or in a water bath reduces efficiency.
  • Antibiotic plates were too warm: Plates should be at room temperature or 37°C, not hot from the incubator, as heat can kill transformed cells.
  • Recovery time too short: Ensure at least 45 minutes of recovery at 37°C with shaking.

If efficiency remains low after troubleshooting, prepare fresh competent cells or use a commercial preparation. See Making Competent Cells for additional guidance.

Contamination Issues

Contamination can arise from several sources:

  • Foreign DNA contamination: Use filter tips and dedicated pipettes for DNA work. Keep plasmid DNA and PCR products separate from competent cells.
  • Bacterial contamination: Work in a laminar flow hood or near a Bunsen burner flame. Use sterile tubes and tips. Autoclave all media and buffers.
  • Phage contamination: DH5a is F⁻, so it is resistant to M13 and filamentous phage infection. However, lytic phages can still infect. If plaques appear on plates, discard all cultures and sterilize the work area.

Satellite Colonies and Antibiotic Concentration

Satellite colonies are small colonies that appear around larger transformed colonies on ampicillin plates. They are non-transformed cells that grow in the zone where the β-lactamase secreted by transformed cells has degraded the ampicillin. To minimize satellite colonies:

  • Use fresh ampicillin plates (prepared within 1–2 weeks).
  • Increase ampicillin concentration to 100 µg/mL.
  • Add 10 mM MgCl₂ to the plates, which reduces satellite formation.
  • Pick colonies from the edge of the plate, away from the main transformed colonies.

For other antibiotics, satellite colonies are less common, but it is still important to use plates of appropriate age and antibiotic concentration.

Summary and Best Practices

DH5a competent cells are a reliable and versatile tool for molecular cloning. The following checklist summarizes the key points for successful use.

Quick Reference Protocol

  1. Thaw DH5a competent cells on ice for 5–10 minutes.
  2. Add 1–10 ng of plasmid DNA or 5–20 µL of ligation reaction.
  3. Incubate on ice for 30 minutes.
  4. Heat shock at 42°C for 30–45 seconds.
  5. Return to ice for 2 minutes.
  6. Add 900 µL pre-warmed SOC medium.
  7. Recover at 37°C with shaking for 45–60 minutes.
  8. Plate on selective agar and incubate at 37°C overnight.

Quality Control Tips

  • Test transformation efficiency with a known supercoiled plasmid (e.g., pUC19) for each new batch of competent cells.
  • Store cells at −80°C in single-use aliquots; avoid repeated freeze-thaw cycles.
  • Use fresh antibiotic plates for selection; old plates lose potency.
  • Confirm all clones by colony PCR, restriction digestion, and sequencing.
  • Maintain a frozen glycerol stock of DH5a for long-term storage; see Cryopreservation of Animal Cells for general principles, though bacterial stocks use 15–25% glycerol in LB.

Frequently Asked Questions

What is the DH5a competent cells protocol?

The standard protocol involves thawing the cells on ice, adding 1–10 ng of plasmid DNA, incubating on ice for 30 minutes, heat shocking at 42°C for 30–45 seconds, returning to ice for 2 minutes, adding SOC medium, and recovering at 37°C for 45–60 minutes before plating on selective agar.

How do I make DH5a competent cells?

Grow DH5a in LB broth to OD₆₀₀ 0.4–0.6, chill on ice, harvest by centrifugation, wash with ice-cold 0.1 M CaCl₂, resuspend in 0.1 M CaCl₂ with 15% glycerol, aliquot, and freeze at −80°C. This yields chemically competent cells with efficiencies of 10⁶–10⁷ CFU/µg.

What is the transformation efficiency of DH5a cells?

Transformation efficiency depends on the preparation method. Homemade chemically competent cells typically achieve 10⁶–10⁷ CFU/µg, while commercial high-efficiency preparations achieve 10⁸–10⁹ CFU/µg. Electrocompetent cells can reach 10⁹–10¹⁰ CFU/µg.

Why are DH5a cells used for cloning?

DH5a carries mutations (recA1, endA1, hsdR17) that prevent recombination, eliminate DNA degradation during plasmid prep, and allow uptake of foreign DNA. The lacZ mutations enable blue-white screening, and the strain supports high-copy plasmid replication.

Can DH5a cells be used for electroporation?

Yes. DH5a can be prepared as electrocompetent cells by washing log-phase cells extensively in ice-cold 10% glycerol. Electroporation yields higher efficiencies than chemical transformation and is useful for large or unstable constructs.

How long can DH5a competent cells be stored?

DH5a competent cells can be stored at −80°C for 6–12 months without significant loss of efficiency. For longer storage, maintain a glycerol stock of the strain itself and prepare fresh competent cells as needed.

What is the difference between DH5a and DH10B competent cells?

DH10B is a derivative of DH5a that carries an additional mutation in mcrA and mrr-hsdRMS-mcrBC, making it more permissive for cloning methylated DNA. DH10B also has higher transformation efficiency and is often used for large-insert cloning and library construction. DH5a is preferred for routine subcloning due to its blue-white screening capability and lower cost. For comparison, see Top10 Competent Cells, which are functionally similar to DH10B.

Key Takeaways

  • DH5a is an E. coli K-12 derivative engineered for high-efficiency plasmid transformation, stable propagation, and blue-white screening.
  • The recA1, endA1, and hsdR17 mutations are essential for plasmid stability, DNA quality, and foreign DNA acceptance, respectively.
  • Chemical competence is induced by calcium chloride treatment and heat shock; electroporation offers higher efficiency but requires specialized equipment.
  • Transformation efficiency depends on cell growth phase, DNA purity and form, and strict adherence to temperature and timing parameters.
  • Antibiotic selection and blue-white screening are the primary methods for identifying transformants; confirmatory analysis by colony PCR and sequencing is essential.
  • Common problems include low efficiency, contamination, and satellite colonies; most can be resolved by careful attention to protocol details.
  • DH5a is not suitable for protein expression or cloning of large or unstable DNA fragments; choose specialized strains for those applications.

Related Clinical & Scientific Guides